CLOSE
Enter your search term and press enter. Press Esc or X to close.

News

pill image

Category: Lachman Consultants

FDA New Draft Guidance Review by Lachman

On Tuesday, the US Food and Drug Administration (FDA) published new draft guidance to help trading partners in the pharmaceutical supply chain request waivers or exemptions from requirements in the Drug Supply Chain and Security Act (DSCSA). The DSCSA, which was signed into law in 2013, aims to build a system by 2023 to identify and trace pharmaceuticals as they are distributed through the US supply chain, including the requirement of placing unique identifiers on medicine packaging that can... Read More
at Friday, May 11, 2018

Improving Health with Lachman Consultants

Another great article authored by our CEO, sounding the call for a change in our perspectives to improving the health of the vulnerably uninsured. Read the full article here ! Read More
at Thursday, March 8, 2018